000			02107cam a2200337 i 4500
001			16640163
003			OSt
005			20191015122406.0
008			110203t20112011ilua b 001 0 eng c
010			_a 2011004666
020			_a9780226045511 (Pbk)
040			_aICU/DLC _beng _cIISER Bhopal _erda _dDLC
042			_apcc
043			_an-us---
050	0	0	_aHD9999.B444 _bH85 2011
082	0	0	_a338.7 H874G _223
100	1		_aHughes, Sally Smith. _925588
245	1	0	_aGenentech : _bthe beginnings of biotech _cSally Smith Hughes.
260			_aLondon : _bUniversity of Chicago Press, _c2011.
300			_axv, 213 pages : _billustrations ; _c24 cm.
490	1		_aSynthesis
504			_aIncludes bibliographical references and index.
505	0		_a1. Inventing recombinant DNA technology ; Scientists on converging paths ;The collaboration ; Patenting and politics ; Steps toward commercialization -- 2. Creating Genentech ; Bob Swanson ; Founding Genentech ; Legal and political obstacles ; A full business plan -- 3. Proving the technology ; A portentous experiment ; Switching targets ; Negotiating research agreements -- Making somatostatin ; Wider issues -- 4. Human insulin: Genentech makes its mark ; Seeking corporate contracts; Procuring a facility and staff ; Genentech's human insulin project ; The Eli Lilly contract ; Publicity and expansion -- 5. Human growth hormone: shaping a commercial future ; Competing for human growth hormone ; Moving toward corporate integration ; Scaling up insulin and growth hormone ; Corporate expansion ; An emerging culture -- 6. Wall Street debut ; Biomania ; Exit strategies ; Interferon: the new wonder drug? ; Run-up to an initial public offering ; Legal impediments ; The IPO.
610	2	0	_aGenentech, Inc. _xHistory. _925589
650		0	_aBiotechnology industries _zUnited States _xHistory. _925590
650		0	_aBiotechnology _xHistory. _925591
830		0	_aSynthesis (University of Chicago. Press) _925592
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cBK
999			_c9042 _d9042